5-bromo-N-[(2E)-6-(methylsulfamoyl)-1,3-benzothiazol-2(3H)-ylidene]pyridine-3-carboxamide结构式
|
常用名 | 5-bromo-N-[(2E)-6-(methylsulfamoyl)-1,3-benzothiazol-2(3H)-ylidene]pyridine-3-carboxamide | 英文名 | 5-bromo-N-[(2E)-6-(methylsulfamoyl)-1,3-benzothiazol-2(3H)-ylidene]pyridine-3-carboxamide |
|---|---|---|---|---|
| CAS号 | 865592-04-7 | 分子量 | 427.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C14H11BrN4O3S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-bromo-N-[(2E)-6-(methylsulfamoyl)-1,3-benzothiazol-2(3H)-ylidene]pyridine-3-carboxamide |
|---|
| 分子式 | C14H11BrN4O3S2 |
|---|---|
| 分子量 | 427.3 |
| InChIKey | HZIFHZUBUZHVOU-UHFFFAOYSA-N |
| SMILES | CNS(=O)(=O)C1=CC2=C(C=C1)N=C(S2)NC(=O)C3=CC(=CN=C3)Br |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|